Nonprofit · EIN 36-3719712
KIDNEY CANCER ASSOCIATION
Also known as KIDNEY CANCER RESEARCH & EDUC ASSN
Tax-exempt · DALLAS, TX 75267
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| October 31, 2025 | 990 | $4,934,440 | $5,900,708 | -$966,268 | $28,252,813 | $2,094,422 | $26,158,391 |
| October 31, 2024 | 990 | $4,942,029 | $5,273,610 | -$331,581 | $26,510,439 | $1,672,474 | $24,837,965 |
| October 31, 2023 | 990 | $2,379,639 | $4,741,209 | -$2,361,570 | $23,797,390 | $2,468,132 | $21,329,258 |
Financial details: 990 for the year ended October 31, 2025
Revenue
- Contributions, gifts and grants
- $3,471,097
- Program service revenue
- $282,399
- Investment income
- $730,749
- Net income from sales of inventory
- -$760
- Other revenue
- $450,195
Expenses
- Grants and similar amounts paid
- $458,325
- Compensation of officers, directors and key employees
- $1,292,869
- Other salaries and wages
- $831,921
- Salaries, compensation and benefits (total)
- $2,549,340
- Professional fundraising fees
- $0
- Legal fees
- $27,469
- Accounting fees
- $131,551
- Occupancy
- $58,321
- Travel
- $249,895
- Depreciation
- $2,326
- Program services (functional)
- $4,945,525
- Management and general (functional)
- $495,444
- Fundraising (functional)
- $459,739
Balance sheet and other
- Total assets, start of year
- $26,510,439
- Total assets, end of year
- $28,252,813
- Total liabilities, end of year
- $2,094,422
- Net assets, end of year
- $26,158,391
- Land, buildings and equipment
- $3,489
- Publicly traded securities
- $25,097,181
- Net assets without donor restrictions
- $24,960,551
- Net assets with donor restrictions
- $1,197,840
- Gross receipts
- $4,936,373
- Employees
- 16
- Volunteers
- 206
- Year formed
- 1990
- State of legal domicile
- IL
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended October 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| GRETCHEN E VAUGHAN | PRESIDENT & CEO Trustee or director, Officer | 40 | $355,063 | $27,909 |
| SALVATORE LA ROSA | CHIEF SCIENTIFIC OFFICER Officer | 40 | $269,537 | $24,485 |
| KENDALL MONROE | CHIEF ADVANCEMENT OFFICER Officer | 40 | $248,498 | $26,525 |
| RADHA CHITALE | SR DIRECTOR OF COMMUNICATIONS Highest-paid employee | 40 | $131,060 | $17,936 |
| ANGELA WASHINGTON | DIRECTOR OF OPERATIONS Highest-paid employee | 40 | $126,087 | $17,687 |
| AMY MARBAUGH | SENIOR DIRECTOR OF PATIENT PROGRAMS Highest-paid employee | 40 | $105,164 | $15,013 |
| BRADLEY LEIBOVICH | MD BOARD CHAIR Trustee or director | 1 | $0 | $0 |
| RYAN NATZKE | VICE CHAIR Trustee or director | 0.5 | $0 | $0 |
| JOEL STERN | TREASURER Trustee or director | 1 | $0 | $0 |
| TESSA CHURCHILL MD | SECRETARY Trustee or director | 0.5 | $0 | $0 |
| LAURENCE ALBIGES MD PHD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| MAHUL B AMIN MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| NOAH BUNTMAN | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| RONALD BUKOWSKI MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| CRAIG DEPRIESTER | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
7 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DANIEL GEORGE MD | DIRECTOR Trustee or director | 0.5 | $0 |
| JAMIE GRAVES | DIRECTOR Trustee or director | 0.5 | $0 |
| DAVID PERRY ESQ | DIRECTOR Trustee or director | 0.5 | $0 |
| SHELLEY ROBSON | DIRECTOR Trustee or director | 0.5 | $0 |
| BRIAN SHUCH MD | DIRECTOR Trustee or director | 0.5 | $0 |
| LAURA WOOD RN | DIRECTOR Trustee or director | 0.5 | $0 |
| RUBEN YBARRA | DIRECTOR Trustee or director | 0.5 | $0 |
990 for the year ended October 31, 2024: 23 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| GRETCHEN VAUGHAN | PRESIDENT & CEO Officer | 40 | $339,752 | $26,851 |
| KENDALL MONROE | CHIEF ADVANCEMENT OFFICER Officer | 40 | $238,378 | $28,538 |
| SALVATORE LA ROSA | CHIEF SCIENTIFIC OFFICER Officer | 40 | $213,177 | $17,180 |
| LARANDA BURKE | CHIEF FINANCIAL OFFICER Officer | 40 | $197,400 | $25,282 |
| RADHA CHITALE | SR. DIRECTOR OF COMMUNICATIONS Highest-paid employee | 40 | $115,359 | $16,343 |
| ANGELA WASHINGTON | DIRCTOR OF OPERATIONS Highest-paid employee | 40 | $114,633 | $16,307 |
| BRADLEY LEIBOVICH MD | BOARD CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| RYAN NATZKE | VICE CHAIR Trustee or director, Officer | 0.5 | $0 | $0 |
| JOEL STERN | TREASURER Trustee or director, Officer | 0.5 | $0 | $0 |
| TESSA CHURCHILL MD | SECRETARY Trustee or director, Officer | 0.5 | $0 | $0 |
| LAURENCE ALBIGES MD PHD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| MAHUL B AMIN MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| NOAH BUNTMAN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| RONALD BUKOWSKI MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| CRAIG DEPRIESTER | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| DANIEL GEORGE MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| JAMIE GRAVES | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| DAVID PERRY ESQ | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| SHELLEY ROBSON | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| BRIAN SHUCH MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| LAURA WOOD RN | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| RUBEN YBARRA | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| MICHAEL NATHAN HAUBRICH | DIRECTOR OF FINANCE Officer | 0.5 | $0 | $0 |
990 for the year ended October 31, 2023: 22 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| GRETCHEN VAUGHAN | PRESIDENT & CEO Officer | 40 | $310,695 | $54,568 |
| KENDALL MONROE | CHIEF ADVANCEMENT OFFICER Officer | 40 | $215,906 | $49,597 |
| LARANDA BURKE | CHIEF FINANCIAL & OPERATING OFFICER Officer | 40 | $169,583 | $33,168 |
| ANGELA WASHINGTON | DIRCTOR OF OPERATIONS Highest-paid employee | 40 | $104,640 | $23,427 |
| RADHA CHITALE | SR. DIRECTOR OF COMMUNICATIONS Highest-paid employee | 40 | $104,354 | $22,346 |
| SALVATORE LA ROSA | CHIEF SCIENTIFIC OFFICER Officer | 40 | $0 | $0 |
| BRADLEY LEIBOVICH MD | BOARD CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| NOAH BUNTMAN | BOARD TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| JOEL STERN | SECRETARY Trustee or director, Officer | 0.5 | $0 | $0 |
| BRIAN SHUCH MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| CRAIG DEPRIESTER | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| DANIEL GEORGE MC | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| DAVID PERRY ESQ | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| JAMIE GRAVES | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| LAURA WOOD RN | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| LAURENCE ALBIGES MD PHD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| MAHUL B AMIN MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| RONALD BUKOWSKI MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| RUBEN YBARRA | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| RYAN NATZKE | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| SHELLEY ROBSON | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
| TESSA CHURCHILL MD | DIRECTOR Trustee or director | 0.5 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- PO BOX 676226, DALLAS, TX 75267-6226
- In care of
- % GRETCHEN E VAUGHAN
- Signed the 990
- GRETCHEN E VAUGHAN, PRESIDENT & CEO
- Phone
- (800) 850-9132
- Website
- WWW.KIDNEYCANCER.ORG
- Return prepared by
- SMART SOLUTIONS CPA INC
Mission
THE KIDNEY CANCER ASSOCIATION IS A GLOBAL COMMUNITY DEDICATED TO SERVING AND EMPOWERING PATIENTS, AND LEADING CHANGE THROUGH ADVOCACY, RESEARCH, AND EDUCATION IN ORDER TO BE THE UNIVERSAL LEADER IN FINDING THE CURE FOR KIDNEY CANCER.
Program accomplishments
- EDUCATION - THE KIDNEY CANCER ASSOCIATION PROVIDES OPPORTUNITIES FOR PHYSICIANS, RESEARCHERS, ACADEMICS, AND INDUSTRY PROFESSIONALS FROM ACROSS THE GLOBE TO COME TOGETHER AND EXCHANGE IDEAS THAT WILL DIRECT THE FUTURE OF KIDNEY CANCER RESEARCH AND TREATMENT IN THE ULTIMATE PURSUIT OF A CURE. THE PRIMARY OPPORTUNITIES ARE DURING THE TWO ANNUAL SYMPOSIA, IKCS NORTH AMERICA AND IKCS EUROPE, HELD BOTH IN PERSON. IKCS MEETINGS PROMOTE LEARNING, NETWORKING, AND UNPARALLELED OPPORTUNITIES FOR MENTORSHIP AND COLLABORATION.Expenses $2,237,246
- PATIENT SUPPORT AND ADVOCACY - THE KIDNEY CANCER ASSOCIATION SEEKS TO BE A SOURCE OF EDUCATION AND RESOURCES FOR PATIENTS, CAREGIVERS, AND ANYONE IMPACTED BY KIDNEY CANCER. THE KCA PROVIDES PATIENT RESOURCES FOR EACH STAGE OF THE KIDNEY CANCER JOURNEY INCLUDING OUR JUST DIAGNOSED TOOLKIT, PATIENT NAVIGATOR PROGRAM, VIRTUAL PATIENT SYMPOSIUM, KCA CONNECT, PATIENT ASSISTANCE FUND, AND EDUCATIONAL RESOURCES INCLUDING INFORMATION ON TREATMENTS, DRUGS, CLINICAL TRIALS, AND CAREGIVING TO NAME A FEW.Expenses $1,497,880 · grants $38,064 · revenue $281,639
- RESEARCH - THE KIDNEY CANCER ASSOCIATION IS COMMITTED TO SUPPORTING HEALTHCARE PROFESSIONALS, FOSTERING PROFESSIONAL COLLABORATION, AND FUNDING RESEARCH THAT ADVANCES OUR UNDERSTANDING OF KIDNEY CANCER. THE ORGANIZATION AWARDED GRANTS TO PHYSICIANS AND SCIENTISTS ENGAGED IN RESEARCH TARGETING EARLY DETECTION AND INNOVATIVE TREATMENTS FOR KIDNEY CANCER.Expenses $1,210,399 · grants $420,261
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in October, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | October 31, 2026 | March 15, 2027 | Not due yet |
| 2024 | October 31, 2025 | March 16, 2026 | 990 on file |
| 2023 | October 31, 2024 | March 17, 2025 | 990 on file |
IRS record
- EIN
- 36-3719712
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1995
- Accounting year ends
- October
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H99H)
- Assets (IRS master file)
- $28,252,813
- Income (IRS master file)
- $4,936,373
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | October 2025 | $4,934,440 | $5,900,708 | $28,252,813 | XML |
| 990 | October 2024 | $4,942,029 | $5,273,610 | $26,510,439 | XML |
| 990 | October 2023 | $2,379,639 | $4,741,209 | $23,797,390 | XML |
| 990 | October 2022 | $6,390,706 | $4,519,204 | $23,316,300 | IRS |
| 990 | October 2021 | – | – | – | IRS |
| 990 | October 2020 | – | – | – | IRS |
| 990 | October 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 36-3719712).
Questions about KIDNEY CANCER ASSOCIATION
- What is the EIN of KIDNEY CANCER ASSOCIATION?
- The employer identification number (EIN) of KIDNEY CANCER ASSOCIATION is 36-3719712.
- Is KIDNEY CANCER ASSOCIATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1995.
- Are donations to KIDNEY CANCER ASSOCIATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does KIDNEY CANCER ASSOCIATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of KIDNEY CANCER ASSOCIATION due?
- The return for tax year 2025 (the year ending October 31, 2026) is due March 15, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did KIDNEY CANCER ASSOCIATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended October 2025.
- Who are the officers and directors of KIDNEY CANCER ASSOCIATION?
- The 990 for the year ended October 31, 2025 lists 22 people; 6 received compensation from the organization, the highest $355,063 (GRETCHEN E VAUGHAN, PRESIDENT & CEO).
- How much revenue does KIDNEY CANCER ASSOCIATION have?
- On its 990 for the year ended October 31, 2025 it reported revenue of $4,934,440, expenses of $5,900,708 and total assets of $28,252,813 at year end.
Other nonprofits in DALLAS
- BAYLOR RESEARCH INSTITUTE EIN 75-1921898 · last filed 990 for 2025
- RETINA FOUNDATION OF THE SOUTHWEST EIN 51-0151514 · last filed 990 for 2025
- CHILDRENS MEDICAL CENTER RESEARCH INSTITUTE AT THE UNIVERSITY OF TEX EIN 45-3462044 · last filed 990 for 2024
- NATIONAL OVARIAN CANCER COALITION INC EIN 65-0628064 · last filed 990 for 2024
- OSTEOSARCOMA INSTITUTE EIN 82-2921815 · last filed 990 for 2024
- DALLAS VA RESEARCH CORPORATION EIN 75-2329831 · last filed 990 for 2025
- PEDIATRIC EPILEPSY RESEARCH FOUNDATION EIN 20-1779737 · last filed 990-PF for 2024
- CHILDRENS CANCER FUND OF DALLAS INC EIN 75-2113401 · last filed 990 for 2025